Telehealth, Default Orders Show Promise in Palliative Care
(MedPage Today) -- A palliative telecare intervention improved quality of life for patients with chronic obstructive pulmonary disease (COPD), heart failure (HF), and interstitial lung disease (ILD), the ADAPT randomized clinical trial found.... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - January 17, 2024 Category: Neurology Source Type: news

Imvaria gets FDA marketing authorization for Fibresolve
The U.S. Food and Drug Administration (FDA) has cleared Imvaria for the use of Fibresolve, a digital biomarker tool that uses AI to guide noninvasive diagnosis of lung fibrosis with a focus on idiopathic pulmonary fibrosis. The company is touting this as the first-ever FDA authorization of a diagnostic tool of any type in lung fibrosis, as well as the first FDA breakthrough-designated AI diagnostic tool with simultaneously adopted current procedural terminology (CPT) billing codes by the American Medical Association (AMA) in any disease. The authorization will speed up the medical community’s access to Fibresolve for d...
Source: AuntMinnie.com Headlines - January 16, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Chest Radiology Source Type: news

This Biomarker Predicts Survival in Autoimmune Lung Disease
(MedPage Today) -- One major subgroup of patients with interstitial lung disease (ILD) arising from polymyositis/dermatomyositis (PM/DM) survived significantly longer when serum levels of interferon-λ3 were relatively low, researchers found... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 28, 2023 Category: Rheumatology Source Type: news

Pneumonia on CT? Consider additional imaging so as not to miss cancer
Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. Suspicion of malignancy may be prompted by avid uptake of the radiopharmaceutical FDG on PET/CT imaging, according to study results delivered on November 27 at the RSNA meeting. But it can be tricky to catch potential cancers once organizing pneumonia has been diagnosed, said presenter Charissa Kim, MD, PhD, of Beth Israel Deaconess Medical Center in New York City. "Accurate ...
Source: AuntMinnie.com Headlines - December 8, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Chest Radiology Nuclear Radiology Source Type: news

Denny Laine, Longtime Member of Paul McCartney ’s Wings and Moody Blues Cofounder, Dies at 79
Denny Laine, the British singer-guitarist best known for his work with Paul McCartney & Wings and the Moody Blues, has died after a long battle with interstitial lung disease, according to a social media post from his wife. He was 79. Born Brian Frederick Hines in 1944 near Birmingham, England, he…#dennylaine #paulmccartneywings #moodyblues #birmingham #rb #bessiebanks #justinhayward #moodies #nights #trevorburton (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news

Conditional Recommendations Rule in New SARD ILD Guidelines Conditional Recommendations Rule in New SARD ILD Guidelines
In spring 2024, the ACR is expected to release guidelines to help inform the screening, monitoring, and treatment of interstitial lung disease (ILD) in people with SARDs.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Interstitial Lung Disease Highlights From CHEST 2023 Interstitial Lung Disease Highlights From CHEST 2023
New insights into antifibrotics in IPF, access to care, and use of artificial intelligence are among the highlights in interstitial lung disease from CHEST 2023 discussed by Dr Fernando J. Martinez.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news

ILD Plus PH Equals Poor Outcomes in Systemic Sclerosis ILD Plus PH Equals Poor Outcomes in Systemic Sclerosis
Patients with systemic sclerosis who have both interstitial lung disease and pulmonary hypertension have worse survival than those without both conditions, based on data from more than 3000 individuals.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - August 30, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news

Outcomes and Risk of PF-ILD in Primary Sjogren's Syndrome Outcomes and Risk of PF-ILD in Primary Sjogren's Syndrome
This study provides new insights into the risk factors and survival outcomes for progressive pulmonary fibrosis among primary Sjogren ' s syndrome patients with interstitial lung disease.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2023 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe Systemic Sclerosis Without Skin Fibrosis Can Still Be Severe
Nearly half of these patients had interstitial lung disease and had similar rates of scleroderma renal crisis, compared with the other disease subtypes.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 29, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

CAR T-Cell Therapy May Treat Antisynthetase Syndrome CAR T-Cell Therapy May Treat Antisynthetase Syndrome
In a case study, a patient with refractory antisynthetase syndrome with progressive myositis and interstitial lung disease showed significant improvement in 8 months after CAR T-cell therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2023 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Check SSc-ILD Patients on Ofev for Malnutrition, Study Suggests
(MedPage Today) -- During nintedanib (Ofev) treatment for interstitial lung disease associated with systemic sclerosis (SSc-ILD), clinicians prescribing the drug should be watchful for an unusual, indirect side effect, trial data suggested. Among... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - June 26, 2023 Category: Rheumatology Source Type: news

Interstitial Lung Disease Highlights From ATS 2023 Interstitial Lung Disease Highlights From ATS 2023
New research from ATS 2023 demonstrates how artificial intelligence may improve diagnosis and prognosis in ILD, and a new therapy shows efficacy for a major comorbidity in this condition.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news

ILD Risk Elevated in RA, PsA After Starting DMARDs ILD Risk Elevated in RA, PsA After Starting DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years was five times higher than for the general population, and the risk was not modified by methotrexate use.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Health Disparities in the Diagnosis and Treatment of Interstitial Lung Disease Health Disparities in the Diagnosis and Treatment of Interstitial Lung Disease
Toby M. Maher, MD, considers the challenges and inequalities faced by patients with interstitial lung disease.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2023 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news